Global Peptide and Heparin Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 116 pages | ID: G58F5247136GEN
GlobalInfoResearch

Abstracts

Peptides are amino acids? short chains connected through peptide bonds. Peptides are molecules that are commonly known as proteins, whose functions are determined on the basis of the amino acid sequence and size. Heparin is known as disaccharide anticoagulant, commonly referred to as blood thinner, which prevents formation of blood clots. Mast cells and basophils in a body produce heparin, which is stored in mast cells and secreted wherever injuries occur.

SCOPE OF THE REPORT:

The global Peptide and Heparin market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Peptide and Heparin.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Peptide and Heparin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Peptide and Heparin market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Eli Lilly
• Novo Nordisk
• Sanofi
• Pfizer
• Abbott Laboratories
• Takeda
• Teva
• Leo Pharma
• Aspen
• Bachem
• Hemmo Pharma
• Sun Pharmaceutical
• Wockhardt
• AmbioPharm

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Intravenous
• Oral Route
• Others

Market Segment by Applications, can be divided into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Contents

1 PEPTIDE AND HEPARIN MARKET OVERVIEW

1.1 Product Overview and Scope of Peptide and Heparin
1.2 Classification of Peptide and Heparin by Types
  1.2.1 Global Peptide and Heparin Revenue Comparison by Types (2017-2023)
  1.2.2 Global Peptide and Heparin Revenue Market Share by Types in 2017
  1.2.3 Intravenous
  1.2.4 Oral Route
  1.2.5 Others
1.3 Global Peptide and Heparin Market by Application
  1.3.1 Global Peptide and Heparin Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Peptide and Heparin Market by Regions
  1.4.1 Global Peptide and Heparin Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Peptide and Heparin Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Peptide and Heparin Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peptide and Heparin Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Peptide and Heparin Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peptide and Heparin Status and Prospect (2013-2023)
1.5 Global Market Size of Peptide and Heparin (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Eli Lilly
  2.1.1 Business Overview
  2.1.2 Peptide and Heparin Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Eli Lilly Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novo Nordisk
  2.2.1 Business Overview
  2.2.2 Peptide and Heparin Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novo Nordisk Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
  2.3.1 Business Overview
  2.3.2 Peptide and Heparin Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Sanofi Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Peptide and Heparin Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Laboratories
  2.5.1 Business Overview
  2.5.2 Peptide and Heparin Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Abbott Laboratories Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.6 Takeda
  2.6.1 Business Overview
  2.6.2 Peptide and Heparin Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Takeda Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva
  2.7.1 Business Overview
  2.7.2 Peptide and Heparin Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Teva Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.8 Leo Pharma
  2.8.1 Business Overview
  2.8.2 Peptide and Heparin Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Leo Pharma Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aspen
  2.9.1 Business Overview
  2.9.2 Peptide and Heparin Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Aspen Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bachem
  2.10.1 Business Overview
  2.10.2 Peptide and Heparin Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Bachem Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.11 Hemmo Pharma
  2.11.1 Business Overview
  2.11.2 Peptide and Heparin Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Hemmo Pharma Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sun Pharmaceutical
  2.12.1 Business Overview
  2.12.2 Peptide and Heparin Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Sun Pharmaceutical Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.13 Wockhardt
  2.13.1 Business Overview
  2.13.2 Peptide and Heparin Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 Wockhardt Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
2.14 AmbioPharm
  2.14.1 Business Overview
  2.14.2 Peptide and Heparin Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 AmbioPharm Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PEPTIDE AND HEPARIN MARKET COMPETITION, BY PLAYERS

3.1 Global Peptide and Heparin Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Peptide and Heparin Players Market Share
  3.2.2 Top 10 Peptide and Heparin Players Market Share
3.3 Market Competition Trend

4 GLOBAL PEPTIDE AND HEPARIN MARKET SIZE BY REGIONS

4.1 Global Peptide and Heparin Revenue and Market Share by Regions
4.2 North America Peptide and Heparin Revenue and Growth Rate (2013-2018)
4.3 Europe Peptide and Heparin Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Peptide and Heparin Revenue and Growth Rate (2013-2018)
4.5 South America Peptide and Heparin Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Peptide and Heparin Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PEPTIDE AND HEPARIN REVENUE BY COUNTRIES

5.1 North America Peptide and Heparin Revenue by Countries (2013-2018)
5.2 USA Peptide and Heparin Revenue and Growth Rate (2013-2018)
5.3 Canada Peptide and Heparin Revenue and Growth Rate (2013-2018)
5.4 Mexico Peptide and Heparin Revenue and Growth Rate (2013-2018)

6 EUROPE PEPTIDE AND HEPARIN REVENUE BY COUNTRIES

6.1 Europe Peptide and Heparin Revenue by Countries (2013-2018)
6.2 Germany Peptide and Heparin Revenue and Growth Rate (2013-2018)
6.3 UK Peptide and Heparin Revenue and Growth Rate (2013-2018)
6.4 France Peptide and Heparin Revenue and Growth Rate (2013-2018)
6.5 Russia Peptide and Heparin Revenue and Growth Rate (2013-2018)
6.6 Italy Peptide and Heparin Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC PEPTIDE AND HEPARIN REVENUE BY COUNTRIES

7.1 Asia-Pacific Peptide and Heparin Revenue by Countries (2013-2018)
7.2 China Peptide and Heparin Revenue and Growth Rate (2013-2018)
7.3 Japan Peptide and Heparin Revenue and Growth Rate (2013-2018)
7.4 Korea Peptide and Heparin Revenue and Growth Rate (2013-2018)
7.5 India Peptide and Heparin Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Peptide and Heparin Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA PEPTIDE AND HEPARIN REVENUE BY COUNTRIES

8.1 South America Peptide and Heparin Revenue by Countries (2013-2018)
8.2 Brazil Peptide and Heparin Revenue and Growth Rate (2013-2018)
8.3 Argentina Peptide and Heparin Revenue and Growth Rate (2013-2018)
8.4 Colombia Peptide and Heparin Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE PEPTIDE AND HEPARIN BY COUNTRIES

9.1 Middle East and Africa Peptide and Heparin Revenue by Countries (2013-2018)
9.2 Saudi Arabia Peptide and Heparin Revenue and Growth Rate (2013-2018)
9.3 UAE Peptide and Heparin Revenue and Growth Rate (2013-2018)
9.4 Egypt Peptide and Heparin Revenue and Growth Rate (2013-2018)
9.5 Nigeria Peptide and Heparin Revenue and Growth Rate (2013-2018)
9.6 South Africa Peptide and Heparin Revenue and Growth Rate (2013-2018)

10 GLOBAL PEPTIDE AND HEPARIN MARKET SEGMENT BY TYPE

10.1 Global Peptide and Heparin Revenue and Market Share by Type (2013-2018)
10.2 Global Peptide and Heparin Market Forecast by Type (2018-2023)
10.3 Intravenous Revenue Growth Rate (2013-2023)
10.4 Oral Route Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)

11 GLOBAL PEPTIDE AND HEPARIN MARKET SEGMENT BY APPLICATION

11.1 Global Peptide and Heparin Revenue Market Share by Application (2013-2018)
11.2 Peptide and Heparin Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)

12 GLOBAL PEPTIDE AND HEPARIN MARKET SIZE FORECAST (2018-2023)

12.1 Global Peptide and Heparin Market Size Forecast (2018-2023)
12.2 Global Peptide and Heparin Market Forecast by Regions (2018-2023)
12.3 North America Peptide and Heparin Revenue Market Forecast (2018-2023)
12.4 Europe Peptide and Heparin Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Peptide and Heparin Revenue Market Forecast (2018-2023)
12.6 South America Peptide and Heparin Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Peptide and Heparin Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Peptide and Heparin Picture
Table Product Specifications of Peptide and Heparin
Table Global Peptide and Heparin and Revenue (Million USD) Market Split by Product Type
Figure Global Peptide and Heparin Revenue Market Share by Types in 2017
Figure Intravenous Picture
Figure Oral Route Picture
Figure Others Picture
Table Global Peptide and Heparin Revenue (Million USD) by Application (2013-2023)
Figure Peptide and Heparin Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Peptide and Heparin Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Peptide and Heparin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Peptide and Heparin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Peptide and Heparin Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Peptide and Heparin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Peptide and Heparin Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Peptide and Heparin Revenue (Million USD) and Growth Rate (2013-2023)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Peptide and Heparin Type and Applications
Table Eli Lilly Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Peptide and Heparin Type and Applications
Table Novo Nordisk Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Peptide and Heparin Type and Applications
Table Sanofi Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Peptide and Heparin Type and Applications
Table Pfizer Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Peptide and Heparin Type and Applications
Table Abbott Laboratories Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Peptide and Heparin Type and Applications
Table Takeda Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Peptide and Heparin Type and Applications
Table Teva Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Leo Pharma Basic Information, Manufacturing Base and Competitors
Table Leo Pharma Peptide and Heparin Type and Applications
Table Leo Pharma Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Peptide and Heparin Type and Applications
Table Aspen Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Bachem Basic Information, Manufacturing Base and Competitors
Table Bachem Peptide and Heparin Type and Applications
Table Bachem Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Hemmo Pharma Basic Information, Manufacturing Base and Competitors
Table Hemmo Pharma Peptide and Heparin Type and Applications
Table Hemmo Pharma Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Peptide and Heparin Type and Applications
Table Sun Pharmaceutical Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Peptide and Heparin Type and Applications
Table Wockhardt Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table AmbioPharm Basic Information, Manufacturing Base and Competitors
Table AmbioPharm Peptide and Heparin Type and Applications
Table AmbioPharm Peptide and Heparin Revenue, Gross Margin and Market Share (2016-2017)
Table Global Peptide and Heparin Revenue (Million USD) by Players (2013-2018)
Table Global Peptide and Heparin Revenue Share by Players (2013-2018)
Figure Global Peptide and Heparin Revenue Share by Players in 2016
Figure Global Peptide and Heparin Revenue Share by Players in 2017
Figure Global Top 5 Players Peptide and Heparin Revenue Market Share in 2017
Figure Global Top 10 Players Peptide and Heparin Revenue Market Share in 2017
Figure Global Peptide and Heparin Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Peptide and Heparin Revenue (Million USD) by Regions (2013-2018)
Table Global Peptide and Heparin Revenue Market Share by Regions (2013-2018)
Figure Global Peptide and Heparin Revenue Market Share by Regions (2013-2018)
Figure Global Peptide and Heparin Revenue Market Share by Regions in 2017
Figure North America Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Europe Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure South America Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Peptide and Heparin Revenue and Growth Rate (2013-2018)
Table North America Peptide and Heparin Revenue by Countries (2013-2018)
Table North America Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure North America Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure North America Peptide and Heparin Revenue Market Share by Countries in 2017
Figure USA Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Canada Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Mexico Peptide and Heparin Revenue and Growth Rate (2013-2018)
Table Europe Peptide and Heparin Revenue (Million USD) by Countries (2013-2018)
Figure Europe Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure Europe Peptide and Heparin Revenue Market Share by Countries in 2017
Figure Germany Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure UK Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure France Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Russia Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Italy Peptide and Heparin Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Peptide and Heparin Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Peptide and Heparin Revenue Market Share by Countries in 2017
Figure China Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Japan Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Korea Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure India Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Peptide and Heparin Revenue and Growth Rate (2013-2018)
Table South America Peptide and Heparin Revenue by Countries (2013-2018)
Table South America Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure South America Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure South America Peptide and Heparin Revenue Market Share by Countries in 2017
Figure Brazil Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Argentina Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Colombia Peptide and Heparin Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Peptide and Heparin Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peptide and Heparin Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Peptide and Heparin Revenue Market Share by Countries in 2017
Figure Saudi Arabia Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure UAE Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Egypt Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure Nigeria Peptide and Heparin Revenue and Growth Rate (2013-2018)
Figure South Africa Peptide and Heparin Revenue and Growth Rate (2013-2018)
Table Global Peptide and Heparin Revenue (Million USD) by Type (2013-2018)
Table Global Peptide and Heparin Revenue Share by Type (2013-2018)
Figure Global Peptide and Heparin Revenue Share by Type (2013-2018)
Figure Global Peptide and Heparin Revenue Share by Type in 2017
Table Global Peptide and Heparin Revenue Forecast by Type (2018-2023)
Figure Global Peptide and Heparin Market Share Forecast by Type (2018-2023)
Figure Global Intravenous Revenue Growth Rate (2013-2018)
Figure Global Oral Route Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Peptide and Heparin Revenue by Application (2013-2018)
Table Global Peptide and Heparin Revenue Share by Application (2013-2018)
Figure Global Peptide and Heparin Revenue Share by Application (2013-2018)
Figure Global Peptide and Heparin Revenue Share by Application in 2017
Table Global Peptide and Heparin Revenue Forecast by Application (2018-2023)
Figure Global Peptide and Heparin Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Peptide and Heparin Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Peptide and Heparin Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Peptide and Heparin Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Peptide and Heparin Revenue Market Forecast (2018-2023)
Figure Europe Peptide and Heparin Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Peptide and Heparin Revenue Market Forecast (2018-2023)
Figure South America Peptide and Heparin Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Peptide and Heparin Revenue Market Forecast (2018-2023)